Fourth Quarter 2021

• GAAP Highlights: Net income attributable to Assured Guaranty Ltd. was $263 million, or $3.74 per share⁽¹⁾, for fourth quarter 2021. Shareholders’ equity attributable to Assured Guaranty Ltd. per share reached a record high of $93.19 as of December 31, 2021.
• Non-GAAP Highlights: Adjusted operating income⁽²⁾ was $273 million, or $3.88 per share, for fourth quarter 2021. Adjusted operating shareholders' equity⁽²⁾ per share and adjusted book value (ABV)⁽²⁾ per share reached record highs of $88.73 and $130.67, respectively, as of December 31, 2021.
• Return of Capital to Shareholders: Fourth quarter 2021 capital returned to shareholders was $207 million, including the repurchase of 3.7 million shares for $192 million, and dividends of $15 million.
• Insurance Segment
  • Insurance segment adjusted operating income was $277 million for fourth quarter 2021.
  • Gross written premiums (GWP) were $100 million for fourth quarter 2021.
  • Present value of new business production (PVP) ⁽²⁾ was $98 million for fourth quarter 2021.
• Asset Management Segment
  • Asset Management segment adjusted operating loss was $3 million for fourth quarter 2021.
  • Assets under management (AUM) inflows were $950 million for fourth quarter 2021.
  • AUM as of December 31, 2021 was $17.5 billion, compared with $17.6 billion as of September 30, 2021. Continuing our strategy to wind down legacy funds, distributions from such funds were $226 million in fourth quarter 2021. 

Full Year (FY) 2021

• GAAP Highlights: Net income attributable to Assured Guaranty Ltd. was $389 million, or $5.23 per share, for FY 2021. FY 2021 included a $175 million pre-tax ($138 million after-tax) loss on debt extinguishment resulting from the voluntary early redemption of certain senior notes.
• Non-GAAP Highlights: Adjusted operating income⁽²⁾ was $470 million, or $6.32 per share, for FY 2021. FY 2021 included a $175 million pre-tax ($138 million after-tax) loss on debt extinguishment resulting from the voluntary early redemption of certain senior notes.
• Return of Capital to Shareholders: FY 2021 capital returned to shareholders was $562 million, including the repurchase of 10.5 million shares (or approximately 14% of shares outstanding at the beginning of 2021) for $496 million, and dividends of $66 million.
• Debt Issuances and Redemptions
  • Issued $500 million of 3.15% senior notes due in 2031.
  • Issued $400 million of 3.6% senior notes due in 2051.
  • Redeemed $600 million of long-term debt with interest rates between 5.000% and 6.875%.
• Insurance Segment
  • Insurance segment adjusted operating income was $722 million for FY 2021.
  • GWP were $377 million for FY 2021.
  • PVP⁽²⁾ was $361 million for FY 2021.
• Asset Management Segment
  • Asset Management segment adjusted operating loss was $19 million for FY 2021.
  • AUM inflows were $3.2 billion for FY 2021.
  • AUM as of December 31, 2021 was $17.5 billion, compared with $17.3 billion as of December 31, 2020. Continuing our strategy to wind down legacy funds, distributions from such funds were $1.0 billion in 2021.

Assured Guaranty Ltd. (NYSE: AGO) (AGL and, together with its consolidated entities, Assured Guaranty or the Company) announced today its financial results for the three-month period ended December 31, 2021 (fourth quarter 2021) and the year ended December 31, 2021 (FY 2021).

“Assured Guaranty’s outstanding 2021 results reflected the success of our uniquely diversified insurance strategy, the effectiveness of our loss mitigation efforts in Puerto Rico and RMBS, and our exercise of prudent capital management,” said Dominic Frederico, President and CEO.

“We more than doubled annual adjusted operating income per share, brought our three principal measures of shareholder value to new highs, and produced $350 million or more of direct PVP for the third consecutive year. With a more than 60% share of insured par issued, we led the municipal bond insurance industry to its highest market penetration in a dozen years. Our insurance business also performed well in international and structured finance markets, and we made significant strides in our asset management business.”

As of December 31, 2021, on a per share basis, shareholders' equity attributable to AGL, adjusted operating shareholders' equity and ABV all reached record highs. The increase in each of these per share measures, as compared with December 31, 2020, was primarily due to positive loss development and the accretive effect of the share repurchase program, partially offset by the loss on extinguishment of debt recognized in the third quarter of 2021. In the case of ABV per share, net premiums written in the Insurance segment also contributed to the increase compared with December 31, 2020. See “Common Share Repurchases” section below.

Fourth Quarter 2021

Insurance Segment

The Insurance segment primarily consists of the Company's insurance subsidiaries that provide credit protection products to the United States (U.S.) and non-U.S. public finance (including infrastructure) and structured finance markets. The Insurance segment is presented without giving effect to the consolidation of FG VIEs; instead, the Insurance segment includes premiums and losses of the financial guaranty insurance policies associated with the FG VIEs' debt. In the case of CIVs, which are primarily funds and collateralized loan obligations (CLOs) managed by Assured Investment Management LLC (AssuredIM LLC) and its investment management affiliates (together with AssuredIM LLC, AssuredIM), the Insurance segment includes the insurance subsidiaries' share of earnings from investments in funds managed by AssuredIM (AssuredIM Funds) in equity in earnings of investees.

Insurance segment adjusted operating income more than doubled to $277 million in fourth quarter 2021, from $109 million in the three-month period ended December 31, 2020 (fourth quarter 2020).

The increase in Insurance segment adjusted operating income was mainly due to the reduction in expected losses on Puerto Rico exposures in fourth quarter 2021. Loss expense in fourth quarter 2020 was primarily attributable to increases in expected losses on Puerto Rico exposures.

Loss expense (benefit) is based on economic loss development (benefit) which was a benefit of $186 million in fourth quarter 2021. In fourth quarter 2021, the Company sold a portion of its salvage and subrogation recoverable asset associated with certain matured Puerto Rico General Obligation and Puerto Rico Electric Power Authority exposures on which the Company had previously paid claims. This sale resulted in proceeds of $383 million, which is included in “net (paid) recovered losses” in the table below. The Company has continued to make such sales, and received an additional $133 million in proceeds in connection with additional such sales in 2022 through February 18, 2022. Also in fourth quarter 2021, the Company increased its assumptions for the value of the remaining contingent value instruments (CVIs) and recovery bonds to be received under the settlement agreements.

Total income generated by the investment portfolio was also higher in fourth quarter 2021 compared with fourth quarter 2020, as shown below.

AssuredIM Funds and other alternative investments generated gains of $44 million in fourth quarter 2021 compared with $24 million in fourth quarter 2020. The increase in equity in earnings was mainly attributable to a large fair value gain on a specific investment in a private equity fund. Equity in earnings of AssuredIM Funds was $10 million in fourth quarter 2021 and was primarily attributable to higher valuations of assets held in the asset-based fund that was launched in the third quarter of 2021. Equity in earnings of AssuredIM Funds was $13 million in fourth quarter 2020 and mainly consisted of earnings in CLO funds, a healthcare fund that was launched in fourth quarter 2020, and the municipal bond fund.

The Insurance segment is authorized to invest up to $750 million in AssuredIM Funds. As of December 31, 2021, the Insurance segment had total commitments to AssuredIM Funds of $702 million, of which $458 million represented net invested capital and $244 million was undrawn. The Insurance segment's interest in AssuredIM Funds was valued at $543 million as of December 31, 2021.

In the Insurance segment, investments in AssuredIM Funds are recorded at net asset value (NAV), with the change in NAV reported in “equity in earnings of investees.” The AssuredIM Funds include healthcare, CLOs, municipal bond and asset-based funds. Equity in earnings of investees also includes the Company's proportionate interests in other alternative investments. To the extent additional fixed-maturity securities are shifted to AssuredIM Funds and other alternative investments, income will also shift from net investment income to equity in earnings of investees.

The benefit of reduced losses in Puerto Rico exposures and higher total investment earnings were partially offset by lower net earned premiums and credit derivative revenues in fourth quarter 2021 of $111 million, compared with $159 million in fourth quarter 2020, which were primarily due to the decline in refundings and terminations as shown below.

New Business Production

GWP relates to both financial guaranty and specialty insurance and reinsurance contracts. Financial guaranty insurance and reinsurance GWP includes: (1) amounts collected upfront on new business written, (2) the present value of future contractual or expected premiums on new business written (discounted at risk-free rates), and (3) the effects of changes in the estimated lives of certain transactions in the in-force book of business. Specialty insurance and reinsurance GWP is recorded as premiums are due. Credit derivatives are accounted for at fair value and therefore are not included in GWP.

The non-GAAP financial measure, PVP, includes upfront premiums and the present value of expected future installments on new business at the time of issuance, discounted at the approximate average pre-tax book yield of fixed-maturity securities purchased during the prior calendar year, for all contracts whether in insurance or credit derivative form. See “Explanation of Non-GAAP Financial Measures” at the end of this press release.

U.S. public finance GWP and PVP in fourth quarter 2021, was lower than the comparable GWP and PVP in fourth quarter 2020, primarily due to reduced average premium rates in 2021 due to tighter credit spreads. The average rating of U.S. public finance par written was A- in fourth quarter 2021, which is consistent with the average rating in fourth quarter 2020. The Company's direct par written represented 61% of the total U.S. municipal market insured issuance in fourth quarter 2021, compared with 54% in fourth quarter 2020, and the Company’s penetration of all municipal issuance increased to 4.6% in fourth quarter 2021 from 3.8% in fourth quarter 2020.

In fourth quarter 2021, non-U.S. public finance GWP and PVP were primarily attributable to the restructuring of several existing transactions that resulted in additional GPW and PVP, without an increase in gross par. Fourth quarter 2021 structured finance GWP and PVP were primarily attributable to insurance securitization transactions and European pooled corporate obligations.

Asset Management Segment

The Asset Management segment consists of AssuredIM, which provides asset management services to third party investors as well as to the Insurance segment.

Asset Management segment adjusted operating loss was $3 million for fourth quarter 2021, compared with $20 million for fourth quarter 2020. The improvement in Asset Management segment results is primarily attributable to an impairment of a lease right-of-use asset of $13 million in fourth quarter 2020, that did not recur in fourth quarter 2021, lower placement fees, and higher management fees.

The increase in management fees in fourth quarter 2021 compared with fourth quarter 2020 is primarily due to higher fees from healthcare opportunity funds launched at the end of 2020, which more than offset the decrease in fees from wind-down funds as distributions to investors continued. As of December 31, 2021, AUM of the wind-down funds was $582 million, compared with $1.6 billion as of December 31, 2020.

Corporate Division

The Corporate division primarily consists of interest expense on the debt of Assured Guaranty US Holdings Inc. (AGUS) and Assured Guaranty Municipal Holdings Inc. (AGMH), as well as other operating expenses attributed to holding company activities.

Other (Effect of FG VIE and CIV consolidation)

The effect of consolidating FG VIEs and CIVs in fourth quarter 2021 was an after-tax gain of $30 million compared with an after-tax loss of $5 million in fourth quarter 2020. In fourth quarter 2021, the Company consolidated an AssuredIM healthcare fund that resulted in a $31 million pre-tax gain on consolidation.

Reconciliation to GAAP

The following table presents a reconciliation of net income (loss) attributable to AGL to adjusted operating income (loss).

Non-credit impairment-related unrealized fair value losses on credit derivatives in fourth quarter 2021 primarily related to a decrease in the Company’s own credit spreads. Non-credit impairment-related fair value gains on credit derivatives in fourth quarter 2020 related primarily to a general tightening in collateral spreads. Except for credit impairment, the fair value adjustments on credit derivatives in the insured portfolio are non-economic adjustments that reverse to zero over the remaining term of that portfolio.

Fair value losses on CCS in fourth quarter 2021 were de minimis, while fair value losses on CCS in fourth quarter 2020 related primarily to a tightening in market spreads during the period. Fair value of CCS is heavily affected by, and in part fluctuates with, changes in market interest rates, credit spreads and other market factors and are not expected to result in an economic gain or loss.

Full Year 2021

Insurance Segment

Insurance segment adjusted operating income for FY 2021 was $722 million, compared with $429 million for the year ended December 31, 2020 (FY 2020). The increase was mainly due to the reduction in expected losses on Puerto Rico exposures in fourth quarter 2021, and higher earnings from the alternative investment portfolio, partially offset by lower net earned premiums and credit derivative revenues. The table below presents the components of loss expense (benefit) included in Insurance segment adjusted operating income.

Loss expense (benefit) is based on economic loss development (benefit), which was an economic benefit of $287 million in FY 2021. The economic benefit for public finance transactions was $204 million primarily due to Puerto Rico exposures. In fourth quarter 2021, the Company sold a portion of its salvage and subrogation recoverable asset associated with certain matured Puerto Rico General Obligation and Puerto Rico Electric Power Authority exposures on which the Company had previously paid claims. This sale resulted in proceeds of $383 million, which is included in “net (paid) recovered losses.” Also in fourth quarter 2021, the Company increased its assumptions for the value of the remaining CVIs and recovery bonds to be received under the settlement agreements. During 2021, the Company also incorporated refinements in certain terms of the Puerto Rico support agreements. The U.S. RMBS economic benefit of $100 million was primarily attributable to higher projected recoveries on charged-off second lien loans, improved performance of certain transactions, the implementation of a recovery assumption on certain deferred principal balances in first lien loans and changes in discount rates, which were all partially offset by lower excess spread.

The table below presents the components of income generated by the investment portfolio.

The total income from the investment portfolio increased due to earnings from alternative investments including investments in AssuredIM Funds, partially offset by lower investment income primarily due to lower average balances in the fixed-maturity investment portfolio, lower reinvestment yields and lower income on loss mitigation securities.

Equity in earnings of AssuredIM Funds in FY 2021 was primarily attributable to higher valuations of assets held in: (i) the healthcare fund that opened at the end of 2020; (ii) CLO funds; and (iii) the asset-based fund that was launched in the third quarter of 2021. Healthcare fund performance was driven by improved financial projections for a number of the portfolio companies as well as upward movement in the traded market multiples of comparable public companies. The CLO funds’ performance was driven by continued tightening of credit spreads. Asset-based fund performance was driven by an improved financial outlook and increases in the market multiples of comparable public companies. In addition, other alternative investments generated gains of $64 million in FY 2021 compared with $19 million in FY 2020 primarily due to a large fair value gain on a specific investment in a private equity fund.

The benefit from the Puerto Rico and U.S. RMBS portfolios and total investment earnings were partially offset by lower net earned premiums and credit derivative revenues in FY 2021 of $438 million compared with $504 million in FY 2020, as shown in the table below, and a commutation gain of $38 million in FY 2020 that did not recur in 2021.

New Business Production

Direct U.S. public finance GWP and PVP decreased in FY 2021 to $220 million and $224 million, respectively, compared with $294 million and $292 million in direct GWP and PVP, respectively, in FY 2020, primarily due to reduced average premium rates in 2021 due to tighter credit spreads. The onset of the COVID-19 pandemic in the first half of 2020 generated an increase in demand for insurance (particularly in the secondary market), and attractive pricing opportunities which were not replicated in 2021 as markets stabilized. The Company's direct par written represented 60% of the total U.S. municipal market insured issuance in FY 2021, compared with 58% in FY 2020, and the Company’s penetration of all municipal issuance increased to 5.0% in FY 2021 from 4.4% in FY 2020.

The Company also assumed U.S. public finance transactions with $833 million in par outstanding in the third quarter of 2021, which generated GWP and PVP of $11 million.

In FY 2021, non-U.S. public finance GWP and PVP included the restructuring of several existing transactions that resulted in additional GWP and PVP, without an increase in gross par, and several large transactions including a large United Kingdom (U.K.) university housing transaction, a U.K. hospital transaction and a renewable energy transaction. Non-U.S public finance GWP and PVP decreased 37% and 4%, respectively. Excluding amounts relating to one large long-dated policy written in 2020, for which GWP includes the present value of all contractual future premiums, while PVP includes the present value of only expected future premiums, non-U.S. public finance GWP and PVP increased 6% and 5%, respectively.

FY 2021 structured finance GWP and PVP were primarily attributable to large insurance securitization transactions and European pooled corporate obligations.

Asset Management Segment

Asset Management segment adjusted operating loss was $19 million for FY 2021, compared with $50 million for FY 2020. The improvement in Asset Management segment results is primarily attributable to (i) an increase in CLO and opportunity fund management fees, which more than offset the decline in management fees from wind-down funds; and (ii) expense reductions that were mainly due to an impairment of a lease right-of-use asset of $13 million in fourth quarter 2020, that did not recur in 2021, and lower placement fees.

CLO fees increased as a result of (i) higher fee-earning CLO AUM over the course of 2021, compared with FY 2020; and (ii) the deferral of CLO fees in FY 2020 that did not recur in FY 2021. CLO fee-earning AUM was $14.3 billion, or 97%, of total CLO AUM as of December 31, 2021, compared with $10.2 billion, or 74%, of total CLO AUM as of December 31, 2020. The increase in fee-earning CLO AUM was primarily due to the sale to third parties of CLO equity from legacy funds, and the issuance of new CLOs. As of December 31, 2021, substantially all of the CLO equity held by legacy funds has been sold to third parties, which ends the fee rebates made back to these funds. In addition, the COVID-19 pandemic and downgrades in loan markets had triggered over-collateralization provisions in CLOs in the second and third quarters of 2020, resulting in the deferral of CLO management fees, which began to recover in the second half of 2020 and the first half of 2021. As of December 31, 2021, there were no CLOs triggering over-collateralization provisions.

Fees from opportunity funds increased primarily due to a full year of management fees earned on the healthcare fund launched at the end of 2020.

In addition to the Asset Management segment results described above, AssuredIM has improved the risk-adjusted return on a portion of the Insurance segment’s investment portfolio, generating $80 million in gains on the AssuredIM Funds in the Insurance segment as described above.

Corporate Division

In 2021 AGUS issued $500 million of 3.15% Senior Notes due in 2031, and $400 million of 3.6% Senior Notes due in 2051.

On July 9, 2021, a portion of the proceeds from the issuance of the 3.15% Senior Notes was used to redeem $200 million of AGMH debt as follows: all $100 million of AGMH's 6 7/8% Quarterly Interest Bonds due in 2101, and $100 million of the $230 million of AGMH's 6.25% Notes due in 2102.

On September 27, 2021, all of the proceeds from the issuance of the 3.6% Senior Notes were used to redeem $400 million of AGMH and AGUS debt as follows: all $100 million of AGMH's 5.60% Notes due in 2103, the remaining $130 million of AGMH 6.25% Notes due in 2102, and $170 million of the $500 million of AGUS 5% Senior Notes due in 2024.

In FY 2021, as a result of these redemptions, the Company recognized a loss on extinguishment of debt of approximately $175 million on a pre-tax basis ($138 million after-tax) which represents the difference between the amount paid to redeem the debt and the carrying value of the debt. The loss on extinguishment of debt primarily consisted of a $156 million acceleration of unamortized fair value adjustments that were originally recorded upon the acquisition of AGMH in 2009, and a $19 million make-whole payment associated with the redemption of $170 million of AGUS 5% Senior Notes. The unamortized fair value adjustments of $156 million that were included in the loss on extinguishment of debt represented a non-cash expense that, had the corresponding debt obligations not been redeemed, would have been recognized as interest expense over the remaining 80+ year terms of those obligations.

Other (Effect of FG VIE and CIV consolidation)

The effect of consolidating FG VIEs and CIVs in FY 2021 was an after-tax gain of $30 million compared with a after-tax loss of $12 million in FY 2020. In FY 2021, the Company consolidated an AssuredIM healthcare fund that resulted in a $31 million pre-tax gain on consolidation.

Reconciliation to GAAP

The following table presents a reconciliation of net income (loss) attributable to AGL to adjusted operating income (loss).

Non-credit impairment-related fair value losses on credit derivatives in FY 2021 primarily related to the lower cost to buy protection on the Company's name. Non-credit impairment-related fair value gains on credit derivatives in FY 2020 primarily related to the increased cost to buy protection on the Company's name.

Fair value losses on CCS in FY 2021 were primarily driven by tightened market spreads during the year. Fair value losses on CCS in FY 2020 were primarily due to a steep reduction in London Interbank Offered Rate, which was partially offset by widened market spreads.

Common Share Repurchases

From 2013 through February 24, 2022, the Company has repurchased 133.7 million common shares at an average price of $31.78, representing approximately 69% of the total shares outstanding at the beginning of the repurchase program in 2013. In 2021 the Company repurchased 10.5 million shares or approximately 14% of shares outstanding at the beginning of 2021. On February 23, 2022, the Board of Directors authorized the repurchase of an additional $350 million of common shares. Under this and previous authorizations, as of February 24, 2022, the Company was authorized to purchase $364 million of its common shares. These repurchases can be made from time to time in the open market or in privately negotiated transactions.

The timing, form and amount of the share repurchases under the program are at the discretion of management and will depend on a variety of factors, including funds available at the parent company, other potential uses for such funds, market conditions, the Company's capital position, legal requirements and other factors, some of which factors may be impacted by the direct and indirect consequences of the course and duration of the COVID-19 pandemic and evolving governmental and private responses to the pandemic. The repurchase program may be modified, extended or terminated by the Board of Directors at any time. It does not have an expiration date.

Financial Statements

Consolidated Balance Sheets (unaudited)

(in millions)